• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

iTRAQ 基于的比较蛋白质组学分析揭示了各种肾脏疾病的特异性尿生物标志物。

iTRAQ-based comparative proteomics analysis reveals specific urinary biomarkers for various kidney diseases.

机构信息

Department of Nephrology, Zhejiang Provincial People's Hospital, Zhejiang 310014, PR China.

Department of Nephrology, People's Hospital of Hangzhou Medical College, Zhejiang 310014, PR China.

出版信息

Biomark Med. 2020 Jul;14(10):839-854. doi: 10.2217/bmm-2019-0556. Epub 2020 Aug 28.

DOI:10.2217/bmm-2019-0556
PMID:32856461
Abstract

Proteome studies for multiple renal diseases is bare. Using isobaric tags for relative and absolute quantitation labeling, many differentially expressed proteins (DEPs) were identified in acute kidney injury (AKI), AKI + chronic kidney disease (CKD), diabetic CKD and nondiabetic CKD with or without IgA nephropathy (IgAN). Comparative analysis indicated that 34, 35, 17, 91 and 14 unique DEPs were found in AKI, AKI + CKD, CKD, diabetic CKD and nondiabetic CKD. Compared with nondiabetic CKD with IgAN, 47 unique DEPs were found in that without IgAN. Serum amyloid A1 (SAA1) and hepatocyte growth factor activator were unregulated in AKI and nondiabetic CKD without IgAN, respectively. Regenerating islet-derived protein 3-α (Reg3A) upregulation is associated with AKI and AKI + CKD patients. This research contributes to urinary biomarker discovery from multiple renal diseases.

摘要

多种肾脏疾病的蛋白质组学研究还很少。使用相对和绝对定量标记的等压标签,在急性肾损伤 (AKI)、AKI+慢性肾脏病 (CKD)、糖尿病 CKD 和非糖尿病 CKD 中发现了许多差异表达蛋白 (DEPs),这些 CKD 患者伴有或不伴有 IgA 肾病 (IgAN)。比较分析表明,AKI、AKI+CKD、CKD、糖尿病 CKD 和非糖尿病 CKD 中分别发现了 34、35、17、91 和 14 个独特的 DEPs。与伴有 IgAN 的非糖尿病 CKD 相比,在不伴有 IgAN 的非糖尿病 CKD 中发现了 47 个独特的 DEPs。血清淀粉样蛋白 A1 (SAA1) 和肝细胞生长因子激活物在 AKI 和非糖尿病 CKD 中无 IgAN 时分别上调。再生胰岛衍生蛋白 3-α (Reg3A) 的上调与 AKI 和 AKI+CKD 患者相关。这项研究有助于从多种肾脏疾病中发现尿液生物标志物。

相似文献

1
iTRAQ-based comparative proteomics analysis reveals specific urinary biomarkers for various kidney diseases.iTRAQ 基于的比较蛋白质组学分析揭示了各种肾脏疾病的特异性尿生物标志物。
Biomark Med. 2020 Jul;14(10):839-854. doi: 10.2217/bmm-2019-0556. Epub 2020 Aug 28.
2
Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.维吾尔族 IgA 肾病患者尿差异蛋白谱分析。
BMC Nephrol. 2018 Dec 14;19(1):358. doi: 10.1186/s12882-018-1139-3.
3
Multisample Mass Spectrometry-Based Approach for Discovering Injury Markers in Chronic Kidney Disease.基于多样本质谱的慢性肾脏病损伤标志物发现方法。
Mol Cell Proteomics. 2021;20:100037. doi: 10.1074/mcp.RA120.002159. Epub 2021 Jan 13.
4
Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.IgA 肾病进展过程中尿补体蛋白的相对定量蛋白质组学分析。
PeerJ. 2023 Apr 11;11:e15125. doi: 10.7717/peerj.15125. eCollection 2023.
5
Urinary cytokeratin 20 as a predictor for chronic kidney disease following acute kidney injury.尿细胞角蛋白 20 作为急性肾损伤后慢性肾脏病的预测因子。
JCI Insight. 2024 May 28;9(13):e180326. doi: 10.1172/jci.insight.180326.
6
Kidney injury biomarkers 5 years after AKI due to pediatric cardiac surgery.儿科心脏手术后急性肾损伤 5 年后的肾损伤生物标志物。
Pediatr Nephrol. 2018 Jun;33(6):1069-1077. doi: 10.1007/s00467-018-3888-4. Epub 2018 Mar 6.
7
Cystatin C as a marker of acute kidney injury in the emergency department.胱抑素 C 作为急诊科急性肾损伤的标志物。
Clin J Am Soc Nephrol. 2010 Oct;5(10):1745-54. doi: 10.2215/CJN.00690110. Epub 2010 Jun 24.
8
Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases.慢性肾脏病患者尿液沉渣中的 micro-RNA 表达。
Dis Markers. 2012;33(3):137-44. doi: 10.1155/2012/842764.
9
[Urinary biomarkers of kidney dysfunction].[肾功能不全的尿液生物标志物]
Ann Biol Clin (Paris). 2015 Mar-Apr;73(2):151-7. doi: 10.1684/abc.2015.1029.
10
Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.尿蛋白质组学作为肾脏病生物标志物发现的新工具。
J Zhejiang Univ Sci B. 2010 Apr;11(4):227-37. doi: 10.1631/jzus.B0900327.

引用本文的文献

1
Exploring the Proteomic Landscape of Cochlear Implant Trauma: An iTRAQ-Based Quantitative Analysis Utilizing an Ex Vivo Model.探索人工耳蜗植入创伤的蛋白质组学全景:基于iTRAQ的定量分析,采用体外模型
J Clin Med. 2025 Jul 18;14(14):5115. doi: 10.3390/jcm14145115.
2
Proteomic analysis of human kidney biopsies unveils emerging acute kidney injury very early after liver graft reperfusion.对人类肾活检组织进行蛋白质组学分析发现,肝移植再灌注后极早期就出现了新发急性肾损伤。
J Transl Med. 2025 Jun 16;23(1):658. doi: 10.1186/s12967-025-06695-w.
3
Identification of Endothelial Cell Protein C Receptor by Urinary Proteomics as Novel Prognostic Marker in Non-Recovery Kidney Injury.
尿蛋白质组学鉴定内皮细胞蛋白 C 受体作为非恢复性肾损伤的新型预后标志物
Int J Mol Sci. 2024 Feb 28;25(5):2783. doi: 10.3390/ijms25052783.
4
Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics.从蛋白质组学推断糖尿病肾病的分子途径
Diabetes Metab Syndr Obes. 2023 Jan 12;16:117-128. doi: 10.2147/DMSO.S392888. eCollection 2023.
5
Urinary Protein and Peptide Markers in Chronic Kidney Disease.慢性肾脏病的尿蛋白和肽标志物。
Int J Mol Sci. 2021 Nov 9;22(22):12123. doi: 10.3390/ijms222212123.